Cordiamine, drops 25% 25 ml

Heart disorder, shock, asphyxiation; poisoning with narcotics, sleeping pills, analgesics.

Indications

Cardiac dysfunction, shock, asphyxia; poisoning with narcotic drugs, sleeping pills, analgesics.

Pharmacological effect

Pharmacotherapeutic group.

Active ingredient

Niketamide

Composition

Drops for oral administration.

1 ml of drops for oral administration contains:

active ingredient:

niketamide 0.25 g.

Contraindications

Predisposition to seizures.

Side Effects

In case of an overdose of Cordiamine, convulsions are possible.

Interaction

The convulsive effect of cordiamine is enhanced by reserpine, the stimulating effect on the respiratory center is eliminated by anesthesia, the effect of the drug is weakened by PAS and saluzide, and aminazine and other phenothiazine derivatives lead to a weakening of the analeptic effect and convulsive effect.

Storage conditions

Store in a place protected from light, at a temperature not exceeding 25ºС.

Shelf life

3 years.

Manufacturer

Technopark-Center, Russia